½ÃÀ庸°í¼­
»óǰÄÚµå
1497719

¼¼°èÀÇ ÀÇ·á ÄÁ¼³ÆÃ ¼­ºñ½º ½ÃÀå ±Ô¸ð¿Í Á¡À¯À² : À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼ö¿ä ¿¹Ãø(-2030³â)

Healthcare Consulting Services Market Size and Share Report by Type, End User - Global Industry Demand Forecast to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Prescient & Strategic Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 270 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÁÖ¿ä ÇÏÀ̶óÀÌÆ®

¼¼°èÀÇ ÀÇ·á ÄÁ¼³ÆÃ ¼­ºñ½º ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 317¾ï ´Þ·¯·Î, 2030³â±îÁö 666¾ï ´Þ·¯¿¡ ´ÞÇϸç, CAGR·Î 11.4%ÀÇ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù.

ÀÌ »ê¾÷ÀÇ ¼ºÀåÀº ÁÖ·Î µðÁöÅÐÈ­°¡ ±Þ¼ÓÈ÷ ¼ö¿ëµÇ°í ÀÖ´Â °Í¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÁÖ¿ä ±â¾÷Àº ÀÇ·á Á¦°øÀÚ¿¡ ´ëÇÑ °æÀï·Â ÀÖ´Â Á¤È®ÇÑ µ¥ÀÌÅÍÀÇ Á¦°øÀ» ÇâÇÑ ±â¼úÀÇ Çâ»ó¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

ÄÁ¼³ÆÃ¿¡¼­ °æºñ »è°¨Àº Áß¿äÇÑ ¿ä¼ÒÀ̸ç, ÀÌ·¯ÇÑ ¼­ºñ½º¸¦ ÅëÇØ Á¶Á÷Àº ÀÎÀû ÀÚº», ÀÚ¿ø °ü¸®, °ø°£, °ü¸® µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ÁöÃâÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

°¢±¹¿¡¼­ °³ÀÎÀÌ °Ç°­ º¸ÇèÀ» ±¸¸ÅÇÒ ¼ö ÀÖ´Â °Ç°­ º¸Çè °Å·¡¼Ò°¡ µîÀåÇϸ鼭 ÀÇ·á ±â¾÷ÀÇ ÀÌÀ± ÆøÀÌ Á¼¾ÆÁö°í ÀÖ½À´Ï´Ù.

¸¹Àº ±¹°¡¿¡¼­ °Ç°­ º¸Çè °Å·¡¼Ò(°æÀï ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ·ÎºÎÅÍ °Ç°­ º¸ÇèÀ» ±¸¸ÅÇÒ ¼ö ÀÖ´Â ¿Â¶óÀÎ ¸¶ÄÏÇ÷¹À̽º)°¡ µîÀåÇϸ鼭 ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ÀÌÀ±Àº ´õ¿í ¾Ð¹ÚÀ» ¹Þ°í ÀÖ½À´Ï´Ù.

º´¿øÀº ÇöÀç °¡Àå ÀÌ»óÀûÀÎ ºñÁî´Ï½º ¸ðµ¨À» ¼±ÅÃÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ´Â ÀÇ·á ÄÁ¼³ÅÏÆ®¸¦ °í¿ëÇϰí ÀÖ½À´Ï´Ù.

°¢±¹ÀÇ ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϱâ À§ÇÑ Á¤ºÎÀÇ Áö¿øÀº »ê¾÷ÀÇ È®ÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

½ÅÈï ±¹°¡À» Áß½ÉÀ¸·Î ÇÑ ÀÇ·á »ê¾÷ÀÇ ¼ºÀåÀº »ê¾÷ ÁøÃâ±â¾÷¿¡°Ô ¸Å·ÂÀûÀÎ ¼ºÀå °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù.

Áß¿ä °í·Á»çÇ×

ºÏ¹Ì´Â 2023³â ¾à 45%ÀÇ Á¡À¯À²À» Â÷ÁöÇÏ¸ç °¡Àå Å« ±â¿©¸¦ ÇÑ ±¹°¡¿´½À´Ï´Ù. ÇâÈÄ 10³â°£ ´õ¿í °­·ÂÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ´Â Àü±¹ ¹× ÁÖ ´ÜÀ§ÀÇ ÀÇ·á Á¤º¸ ±³È¯ ±¸ÃàÀ» À§ÇÑ Ç³ºÎÇÑ Á¤ºÎ Àڱݰú ÀÇ·á IT ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ëÀÌ ÁøÇà ÁßÀ̱⠶§¹®ÀÔ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇâÈÄ ¼ö³â°£ °¡Àå ºü¸¥ CAGR·Î ¹ßÀüÇÒ °ÍÀÔ´Ï´Ù.

ÀÌ´Â ±¹³»¿Ü ÀÇ·á ±â¾÷ÀÇ ÅõÀÚ Áõ°¡, ¼÷·ÃµÈ ÀÎÀç Áý´Ü, ÀÇ·á µðÁöÅÐÈ­¸¦ À§ÇÑ Á¤ºÎÀÇ ±¸»ó, ÀÇ·á ÀÎÇÁ¶óÀÇ °íµµÈ­ µî¿¡ ±âÀÎÇÕ´Ï´Ù.

2023³â, °æ¿µ ÄÁ¼³ÆÃ ºÐ¾ß°¡ 60%ÀÇ Á¡À¯À²·Î ¾÷°è¸¦ ÁÖµµÇß½À´Ï´Ù.

ÀÌ´Â °æ¿µ»óÀÇ ¾î·Á¿ò, °¢Á¾ Áúº´ÀÇ À¯º´·ü Áõ°¡, ÀǾàǰ ¼ö¿ä Áõ°¡, Á¤ºÎÀÇ À¯¿ëÇÑ Á¤Ã¥, ÀÇ·á ÀÎÇÁ¶ó °³¼± µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù.

ÀÇ·á ºÎ¹®ÀÌ Fee-for-Service¿¡¼­ ÄÚµð³×ÀÌÆÃ ÄÉ¾î ¸ðµ¨·Î ÀüȯÇÔ¿¡ µû¶ó °æ¿µ ÄÁ¼³ÅÏÆ®¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ÀÌ´Â »ê¾÷ÀÇ È®ÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù.

µðÁöÅÐ Çコ ÄÁ¼³ÆÃ Ä«Å×°í¸®´Â Áö³­ 10³â°£ °¡Àå ºü¸¥ CAGR·Î ¹ßÀüÇÒ °¡´É¼ºÀÌ ³ôÀº ºÐ¾ßÀÔ´Ï´Ù.

ÀÌ´Â ÀÇ·á ºÎ¹®¿¡¼­ Çõ½ÅÀûÀÎ ±â¼úÀÌ ¼ö¿ëµÇ°í ÀÖÀ¸¸ç, ƯÈ÷ ¼±Áø±¹¿¡¼­´Â Á¾ÀÌ ±â¹Ý °ü¸® ¹æ½Äº¸´Ù µðÁöÅÐ ¼Ö·ç¼ÇÀÌ ´õ ¸¹ÀÌ ¹Þ¾Æµé¿©Áö°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷Àº ÀÌ »ê¾÷¿¡ Å« ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù.

±× ¹è°æ¿¡´Â IT ¹× ¾÷¹« ÀýÂ÷ ó¸®ÀÇ ´Ù¾çÇÑ °úÁ¦¿Í ²÷ÀÓ¾øÀÌ º¯È­ÇÏ´Â ºñÁî´Ï½º ¿ªÇÐÀ» ÇØ°áÇØ¾ß ÇÑ´Ù´Â Á¡ÀÌ ÀÖ½À´Ï´Ù.

Á¤ºÎ ±â°ü Ä«Å×°í¸®´Â ÇâÈÄ 10³â°£ ³ôÀº CAGR·Î ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¸ðµç ½ÅÈï °æÁ¦±¹ Á¤ºÎ°¡ ÀÇ·á ÀÎÇÁ¶ó¿Í °æÁ¦¸¦ °­È­Çϱâ À§ÇÑ °èȹÀ» ¼¼¿ì°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

ÄÁ¼³ÆÃ ¼­ºñ½º´Â ¾î¶² Á¶Á÷À̳ª ±¹°¡µç ÀÇ·á ÀÎÇÁ¶ó¸¦ °­È­ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ÀÇ·á ÄÁ¼³ÆÃ ¼­ºñ½º ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ¿ªÇÐ, Áö¿ª°ú ºÎ¹®º° ½ÃÀå ¸ÅÃâ, °æÀï ±¸µµ µîÀÇ Á¤º¸¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹üÀ§

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå »ê¾÷ Àü¹®°¡/KOLÀÇ ¼Ò¸®

Á¦5Àå ½ÃÀåÀÇ ÁöÇ¥

Á¦6Àå »ê¾÷ Àü¸Á

  • ½ÃÀå ¿ªÇÐ
    • µ¿Çâ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ/°úÁ¦
    • ÃËÁø¿äÀÎ/¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®
  • COVID-19ÀÇ ¿µÇâ
  • Porter's Five Forces ºÐ¼®

Á¦7Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷°ú Á¦°øÇ° ¸®½ºÆ®
  • ÁÖ¿ä ±â¾÷ÀÇ °æÀï º¥Ä¡¸¶Å·
  • ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° º¥Ä¡¸¶Å·
  • ÃÖ±Ù Àü·«Àû ¹ßÀü

Á¦8Àå ¼¼°è ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : Áö¿ªº°(2017-2030³â)

Á¦9Àå ºÏ¹Ì ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ±¹°¡º°(2017-2030³â)

Á¦10Àå À¯·´ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ±¹°¡º°(2017-2030³â)

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ±¹°¡º°(2017-2030³â)

Á¦12Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ±¹°¡º°(2017-2030³â)

Á¦13Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ±¹°¡º°(2017-2030³â)

Á¦14Àå ¹Ì±¹ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦15Àå ij³ª´Ù ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦16Àå µ¶ÀÏ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦17Àå ÇÁ¶û½º ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦18Àå ¿µ±¹ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦21Àå Áß±¹ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦22Àå ÀϺ» ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦23Àå Àεµ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦24Àå Çѱ¹ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦25Àå È£ÁÖ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦26Àå ºê¶óÁú ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦27Àå ¸ß½ÃÄÚ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦28Àå »ç¿ìµð¾Æ¶óºñ¾Æ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦29Àå ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦30Àå ¾Æ¶ø¿¡¹Ì¸®Æ® ½ÃÀå

  • °³¿ä
  • ½ÃÀå ¸ÅÃâ : À¯Çüº°(2017-2030³â)
  • ½ÃÀå ¸ÅÃâ : ÃÖÁ¾»ç¿ëÀÚº°(2017-2030³â)

Á¦31Àå ±â¾÷ °³¿ä

  • Accenture plc
  • Cognizant Technology Solutions Corporation
  • Deloitte Touche Tohmatsu Limited
  • McKinsey & Company
  • PricewaterhouseCoopers LLP
  • Ernst & Young Global Limited
  • Huron Consulting Group
  • KPMG International Limited
  • Boston Consulting Group Inc.
  • Bain & Company Inc.
  • IQVIA Inc.

Á¦32Àå ºÎ·Ï

KSA 24.06.26

Key Highlights

The healthcare consulting services market was valued at USD 31.7 billion in 2023, and it will increase to USD 66.6 billion, propelling at an 11.4% compound annual growth rate, by 2030.

The growth of this industry is mainly ascribed to the rapid acceptance of digitalization.

Key companies offering healthcare these services are focusing on bringing technological improvements for offering competitive and precise data to healthcare providers.

Reducing expenses is an important factor in consulting, and by utilizing these services, organizations may reduce spending in different areas, such as human capital, resource management, space, and operations.

The arrival of health insurance exchanges, where individuals can purchase health insurance, across different nations has tightened the profit margins for healthcare firms.

The advent of health insurance exchanges (online marketplaces to purchase health insurance from competing providers) across many nations has put further strain on the margins of healthcare providers.

Hospitals, now, are hiring healthcare consultants for assistance with selecting for the most ideal business models.

The rising government's support to improve the healthcare infrastructure in their respective nations will boost industry expansion.

The growth of the healthcare industry, mainly in emerging economies, offers an appealing growth potential for industry participants.

Key Insights

North America was the largest contributor to the industry in 2023, with approximately 45% share, and it will further grow at a robust CAGR during this decade.

This is because of the ample government funding for creating nationwide and state-wide healthcare information exchanges, coupled with the increasing acceptance of healthcare IT solutions.

APAC will advance at the fastest compound annual growth rate in the years to come.

This will be because of the rising investment by both foreign and domestic healthcare firms, a large pool of skilled individuals, the government effort for healthcare digitalization, and the advancement of the healthcare infrastructure.

The operations consulting category led the industry in 2023, with a 60% share.

This is because of the challenges in operations, the rising prevalence of different kinds of diseases, the increasing need for drugs, helpful government policies, and improvements in the healthcare infrastructure.

A larger dependence on operational consultants due to the medical sector's move from a fee-for-service to a coordinated care model will boost industry expansion.

The digital health consulting category is likely to advance at the fastest compound annual growth rate during this decade.

This is because of the acceptance of innovative technologies in the medical area, notably digital solutions over paper-based administrative methods in developed nations.

Pharmaceutical & biotechnology companies are significant contributors to the industry.

This can be because of the variety of challenges they must tackle in handling their IT and operational procedures, along with their continuously changing business dynamics.

The government bodies category will advance at a significant CAGR during this decade. This is because all the emerging economies governments are making plans to enhance their healthcare infrastructure and economy.

Consulting services play an important part in enhancing the healthcare infrastructure in any organization and nation, as they offer the tactic for the purpose and to boost operations.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by end user
    • 1.4.3. Market size breakdown, by region
    • 1.4.4. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

  • 6.1. Market Dynamics
    • 6.1.1. Trends
    • 6.1.2. Drivers
    • 6.1.3. Restraints/challenges
    • 6.1.4. Impact analysis of drivers/restraints
  • 6.2. Impact of COVID-19
  • 6.3. Porter's Five Forces Analysis
    • 6.3.1. Bargaining power of buyers
    • 6.3.2. Bargaining power of suppliers
    • 6.3.3. Threat of new entrants
    • 6.3.4. Intensity of rivalry
    • 6.3.5. Threat of substitutes

Chapter 7. Competitive Landscape

  • 7.1. List of Market Players and their Offerings
  • 7.2. Competitive Benchmarking of Key Players
  • 7.3. Product Benchmarking of Key Players
  • 7.4. Recent Strategic Developments

Chapter 8. Global Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Type (2017-2030)
  • 8.3. Market Revenue, by End User (2017-2030)
  • 8.4. Market Revenue, by Region (2017-2030)

Chapter 9. North America Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Type (2017-2030)
  • 9.3. Market Revenue, by End User (2017-2030)
  • 9.4. Market Revenue, by Country (2017-2030)

Chapter 10. Europe Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Type (2017-2030)
  • 10.3. Market Revenue, by End User (2017-2030)
  • 10.4. Market Revenue, by Country (2017-2030)

Chapter 11. APAC Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Type (2017-2030)
  • 11.3. Market Revenue, by End User (2017-2030)
  • 11.4. Market Revenue, by Country (2017-2030)

Chapter 12. LATAM Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Type (2017-2030)
  • 12.3. Market Revenue, by End User (2017-2030)
  • 12.4. Market Revenue, by Country (2017-2030)

Chapter 13. MEA Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Type (2017-2030)
  • 13.3. Market Revenue, by End User (2017-2030)
  • 13.4. Market Revenue, by Country (2017-2030)

Chapter 14. U.S. Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Type (2017-2030)
  • 14.3. Market Revenue, by End User (2017-2030)

Chapter 15. Canada Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Type (2017-2030)
  • 15.3. Market Revenue, by End User (2017-2030)

Chapter 16. Germany Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Type (2017-2030)
  • 16.3. Market Revenue, by End User (2017-2030)

Chapter 17. France Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Type (2017-2030)
  • 17.3. Market Revenue, by End User (2017-2030)

Chapter 18. U.K. Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Type (2017-2030)
  • 18.3. Market Revenue, by End User (2017-2030)

Chapter 19. Italy Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Type (2017-2030)
  • 19.3. Market Revenue, by End User (2017-2030)

Chapter 20. Spain Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Type (2017-2030)
  • 20.3. Market Revenue, by End User (2017-2030)

Chapter 21. China Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Type (2017-2030)
  • 21.3. Market Revenue, by End User (2017-2030)

Chapter 22. Japan Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Type (2017-2030)
  • 22.3. Market Revenue, by End User (2017-2030)

Chapter 23. India Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Type (2017-2030)
  • 23.3. Market Revenue, by End User (2017-2030)

Chapter 24. South Korea Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Type (2017-2030)
  • 24.3. Market Revenue, by End User (2017-2030)

Chapter 25. Australia Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Type (2017-2030)
  • 25.3. Market Revenue, by End User (2017-2030)

Chapter 26. Brazil Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Type (2017-2030)
  • 26.3. Market Revenue, by End User (2017-2030)

Chapter 27. Mexico Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Type (2017-2030)
  • 27.3. Market Revenue, by End User (2017-2030)

Chapter 28. Saudi Arabia Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Type (2017-2030)
  • 28.3. Market Revenue, by End User (2017-2030)

Chapter 29. South Africa Market

  • 29.1. Overview
  • 29.2. Market Revenue, by Type (2017-2030)
  • 29.3. Market Revenue, by End User (2017-2030)

Chapter 30. U.A.E. Market

  • 30.1. Overview
  • 30.2. Market Revenue, by Type (2017-2030)
  • 30.3. Market Revenue, by End User (2017-2030)

Chapter 31. Company Profiles

  • 31.1. Accenture plc
    • 31.1.1. Business overview
    • 31.1.2. Product and service offerings
    • 31.1.3. Key financial summary
  • 31.2. Cognizant Technology Solutions Corporation
    • 31.2.1. Business overview
    • 31.2.2. Product and service offerings
    • 31.2.3. Key financial summary
  • 31.3. Deloitte Touche Tohmatsu Limited
    • 31.3.1. Business overview
    • 31.3.2. Product and service offerings
    • 31.3.3. Key financial summary
  • 31.4. McKinsey & Company
    • 31.4.1. Business overview
    • 31.4.2. Product and service offerings
    • 31.4.3. Key financial summary
  • 31.5. PricewaterhouseCoopers LLP
    • 31.5.1. Business overview
    • 31.5.2. Product and service offerings
    • 31.5.3. Key financial summary
  • 31.6. Ernst & Young Global Limited
    • 31.6.1. Business overview
    • 31.6.2. Product and service offerings
    • 31.6.3. Key financial summary
  • 31.7. Huron Consulting Group
    • 31.7.1. Business overview
    • 31.7.2. Product and service offerings
    • 31.7.3. Key financial summary
  • 31.8. KPMG International Limited
    • 31.8.1. Business overview
    • 31.8.2. Product and service offerings
    • 31.8.3. Key financial summary
  • 31.9. Boston Consulting Group Inc.
    • 31.9.1. Business overview
    • 31.9.2. Product and service offerings
    • 31.9.3. Key financial summary
  • 31.10. Bain & Company Inc.
    • 31.10.1. Business overview
    • 31.10.2. Product and service offerings
    • 31.10.3. Key financial summary
  • 31.11. IQVIA Inc.
    • 31.11.1. Business overview
    • 31.11.2. Product and service offerings
    • 31.11.3. Key financial summary

Chapter 32. Appendix

  • 32.1. Abbreviations
  • 32.2. Sources and References
  • 32.3. Related Reports
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦